Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schnaider Beeri, M.
Right arrow Articles by Davidson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schnaider Beeri, M.
Right arrow Articles by Davidson, M.
Related Collections
Right arrow Endocrine
Right arrow All Neuropsychology/Behavior
Right arrow All Cognitive Disorders/Dementia
Right arrow Alzheimer's disease
Right arrow Vascular dementia
Right arrow Risk factors in epidemiology
NEUROLOGY 2004;63:1902-1907
© 2004 American Academy of Neurology

Diabetes mellitus in midlife and the risk of dementia three decades later

M. Schnaider Beeri, PhD, U. Goldbourt, PhD, J. M. Silverman, PhD, S. Noy, MD, J. Schmeidler, PhD, R. Ravona-Springer, MD, A. Sverdlick, MD and M. Davidson, MD

From the Department of Psychiatry (Drs. Schnaider Beeri and Silverman) and Biomathematical Sciences Department (Dr. Schmeidler), Mount Sinai School of Medicine, New York, NY; Division of Epidemiology and Preventive Medicine (Dr. Goldbourt), Sackler Medical Faculty, Tel Aviv University; and Neufeld Cardiac Research Institute (Dr. Goldbourt) and Department of Psychiatry (Drs. Noy, Ravona-Springer, Sverdlick, and Davidson), Sheba Medical Center, Tel Hashomer, Israel.

Address correspondence and reprint requests to Dr. Michal Schnaider Beeri, Mount Sinai School of Medicine, Department of Psychiatry, One Gustave Levy Place, Box 1230, New York, NY 10029; e-mail: michal.beeri{at}mssm.edu

Objective: To examine the association between diabetes in midlife (1963–1968) and dementia more than three decades later (1999–2001).

Methods: The authors characterized dementia using standard methods for 1,892 participants among 2,606 survivors of 10,059 participants in the Israeli Ischemic Heart Disease study, a longitudinal investigation of the incidence of and risk factors for cardiovascular disease among Jewish male civil servants in Israel. Face to face interviews were conducted with the 652 subjects identified as possibly demented by the Modified Telephone Interview for Cognitive Status. Logistic regression analysis was performed to assess the association of diabetes with dementia controlling for sociodemographic and cardiovascular variables compared to those with no cognitive impairment.

Results: Of 1,892 assessed subjects (mean age 82 at assessment), 309 (16.3%) had dementia. Diabetic subjects had significantly more dementia than non-diabetic subjects ({chi}2 = 7.54, df = 1, p = 0.006, OR 2.83 [95% CI = 1.40 to 5.71]). Those who survived to the time of this study were younger and healthier than those who died.

Conclusions: Evidence for diabetes as a risk factor for dementia was found, similar to other epidemiologic studies. In contrast to the earlier studies, however, the authors linked diabetes in midlife to dementia more than three decades later in the very old survivors of a large male cohort.

Received October 3, 2003. Accepted in final form July 16, 2004.




This article has been cited by other articles:


Home page
 AJGPHome page
C.-J. Chiang, P.-K. Yip, S.-C. Wu, C.-S. Lu, C.-W. Liou, H.-C. Liu, C.-K. Liu, C.-H. Chu, C.-S. Hwang, S.-F. Sung, et al.
Midlife Risk Factors for Subtypes of Dementia: A Nested Case-Control Study in Taiwan
Am J Geriatr Psychiatry, September 1, 2007; 15(9): 762 - 771.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. Xu, C. Qiu, B. Winblad, and L. Fratiglioni
The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer's Disease
Diabetes, January 1, 2007; 56(1): 211 - 216.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Z. Arvanitakis, J. A. Schneider, R. S. Wilson, Y. Li, S. E. Arnold, Z. Wang, and D. A. Bennett
Diabetes is related to cerebral infarction but not to AD pathology in older persons
Neurology, December 12, 2006; 67(11): 1960 - 1965.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. J. Clodfelder-Miller, A. A. Zmijewska, G. V.W. Johnson, and R. S. Jope
Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency
Diabetes, December 1, 2006; 55(12): 3320 - 3325.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Akomolafe, A. Beiser, J. B. Meigs, R. Au, R. C. Green, L. A. Farrer, P. A. Wolf, and S. Seshadri
Diabetes Mellitus and Risk of Developing Alzheimer Disease: Results From the Framingham Study
Arch Neurol, November 1, 2006; 63(11): 1551 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. S. Beeri, M. Rapp, J. M. Silverman, J. Schmeidler, H. T. Grossman, J. T. Fallon, D. P. Purohit, D. P. Perl, A. Siddiqui, G. Lesser, et al.
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
Neurology, May 9, 2006; 66(9): 1399 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Aragno, R. Mastrocola, C. Medana, F. Restivo, M. G. Catalano, N. Pons, O. Danni, and G. Boccuzzi
Up-Regulation of Advanced Glycated Products Receptors in the Brain of Diabetic Rats Is Prevented by Antioxidant Treatment
Endocrinology, December 1, 2005; 146(12): 5561 - 5567.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.